Donor-transmitted adenovirus infection causing kidney allograft nephritis and graft loss

Transplant Infectious Disease

Volumn 13, Issue 2, 2011, Pages 168-173

  Kozlowski, T ^a   Nickeleit, V ^b   Andreoni, K ^a,c  

^a Department of Surgery ^*  (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Adenovirus; Immunosuppression; Kidney transplant; Transmitted infection

Indexed keywords

ALEMTUZUMAB; COTRIMOXAZOLE; CREATININE; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ADENOVIRUS INFECTION; ADULT; ARTICLE; CASE REPORT; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; GRAFT FAILURE; GRAFT INFECTION; GRAFT NECROSIS; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY NECROSIS; MALE; NEPHRECTOMY; NEPHRITIS; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADENOVIRUS INFECTIONS, HUMAN; ADULT; CHILD, PRESCHOOL; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TISSUE DONORS; YOUNG ADULT;

EID: 79953320830     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2010.00572.x     Document Type: Article

References (23)

1. Emovon OE, Chavin J, Rogers K, Self S. Adenovirus in kidney transplantation: an emerging pathogen? Transplantation 2004; 77 (9): 1474-1475.
2. Carter BA, Karpen SJ, Quiros-Tejeira RE, et al. Intravenous cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient. Transplantation 2002; 74 (7): 1050-1052.
3. Kim SS, Hicks J, Goldstein SL. Adenovirus pyelonephritis in a pediatric renal transplant patient. Pediatr Nephrol 2003; 18 (5): 457-461.
4. McLaughlin GE, Delis S, Kashimawo L, et al. Adenovirus infection in pediatric liver and intestinal transplant recipients: utility of DNA detection by PCR. Am J Transplant 2003; 3 (2): 224-228.
5. Humar A, Kumar D, Mazzulli T, et al. A surveillance study of adenovirus infection in adult solid organ transplant recipients. Am J Transplant 2005; 5 (10): 2555-2559.
6. Baldwin A, Kingman H, Darville M, et al. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant 2000; 26 (12): 1333-1338.
7. Hensley JL, Sifri CD, Cathro HP, et al. Adenoviral graft-nephritis: case report and review of the literature. Transpl Int 2009; 22 (6): 672-677.
8. Hatakeyama N, Suzuki N, Kudoh T, Hori T, Mizue N, Tsutsumi H. Successful cidofovir treatment of adenovirus-associated hemorrhagic cystitis and renal dysfunction after allogenic bone marrow transplant. Pediatr Infect Dis J 2003; 22 (10): 928-929.
9. Emovon OE, Lin A, Howell DN, et al. Refractory adenovirus infection after simultaneous kidney-pancreas transplantation: successful treatment with intravenous ribavirin and pooled human intravenous immunoglobulin. Nephrol Dial Transplant 2003; 18 (11): 2436-2438.
10. Arav-Boger R, Echavarria M, Forman M, Charache P, Persaud D. Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient. Pediatr Infect Dis J 2000; 19 (11): 1097-1100.
11. Agha IA, Rueda J, Alvarez A, et al. Short course induction immunosuppression with thymoglobulin for renal transplant recipients. Transplantation 2002; 73 (3): 473-475.
12. Matas AJ, Ramcharan T, Paraskevas S, et al. Rapid discontinuation of steroids in living donor kidney transplantation: a pilot study. Am J Transplant 2001; 1 (3): 278-283.
13. Peddi VR, Bryant M, Roy-Chaudhury P, Woodle ES, First MR. Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients. Transplantation 2002; 73 (9): 1514-1518.
14. Shirali GS, Ni J, Chinnock RE, Johnston JK, et al. Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med 2001; 344 (20): 1498-1503.
15. Ciancio G, Burke GW 3rd. Alemtuzumab (Campath-1H) in kidney transplantation. Am J Transplant 2008; 8 (1): 15-20.
16. Hierholzer JC. Adenoviruses in the immunocompromised host. Clin Microbiol Rev 1992; 5 (3): 262-274.
17. Rosario RF, Kimbrough RC, Van Buren DH, Laski ME. Fatal adenovirus serotype-5 in a deceased-donor renal transplant recipient. Transpl Infect Dis 2006; 8 (1): 54-57.
18. Echavarria M, Forman M, Ticehurst J, Dumler JS, Charache P. PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virus-infected individuals. J Clin Microbiol 1998; 36 (11): 3323-3326.
19. Echavarria M, Forman M, van Tol MJ, Vossen JM, Charache P, Kroes AC. Prediction of severe disseminated adenovirus infection by serum PCR. Lancet 2001; 358 (9279): 384-385.
20. Schilham MW, Claas EC, van Zaane W, et al. High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clin Infect Dis 2002; 35 (5): 526-532.
21. Seidemann K, Heim A, Pfister ED, et al. Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: report of six cases and review of the literature. Am J Transplant 2004; 4 (12): 2102-2108.
22. Teramura T, Naya M, Yoshihara T, Kanoh G, Morimoto A, Imashuku S. Adenoviral infection in hematopoietic stem cell transplantation: early diagnosis with quantitative detection of the viral genome in serum and urine. Bone Marrow Transplant 2004; 33 (1): 87-92.
23. Humar A, Doucette K, Kumar D, et al. Assessment of adenovirus infection in adult lung transplant recipients using molecular surveillance. J Heart Lung Transplant 2006; 25 (12): 1441-1446.